Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
542 questions in 42 reviews · Skin
current versionsNo studies 542 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Cefadroxil vs flucloxacillin Recurrence of folliculitis or boil following completion of treatment · bacterial furunculosis Interventions for bacterial folliculitis and boils (furuncles and carbuncles) (2021) · Cochrane | no estimate extracted | NR | No studies |
Topical antibiotics vs topical antiseptics Severe adverse events leading to withdrawal of treatment · bacterial folliculitis and boils (furuncles and carbuncles) Interventions for bacterial folliculitis and boils (furuncles and carbuncles) (2021) · Cochrane | no estimate extracted | NR | No studies |
Cefdinir vs cefalexin Quality of life · bacterial folliculitis and boils (furuncles and carbuncles) Interventions for bacterial folliculitis and boils (furuncles and carbuncles) (2021) · Cochrane | no estimate extracted | NR | No studies |
Cefdinir vs cefalexin Recurrence of folliculitis or boil following completion of treatment · bacterial folliculitis and boils (furuncles and carbuncles) Interventions for bacterial folliculitis and boils (furuncles and carbuncles) (2021) · Cochrane | no estimate extracted | NR | No studies |
Azithromycin vs cefaclor Quality of life · bacterial boils (furuncles and carbuncles) Interventions for bacterial folliculitis and boils (furuncles and carbuncles) (2021) · Cochrane | no estimate extracted | NR | No studies |
Azithromycin vs cefaclor Recurrence of folliculitis or boil following completion of treatment · bacterial boils (furuncles and carbuncles) Interventions for bacterial folliculitis and boils (furuncles and carbuncles) (2021) · Cochrane | no estimate extracted | NR | No studies |
Topical antibiotics vs topical antiseptics Quality of life · bacterial folliculitis and boils (furuncles and carbuncles) Interventions for bacterial folliculitis and boils (furuncles and carbuncles) (2021) · Cochrane | no estimate extracted | NR | No studies |
Cefditoren pivoxil vs cefaclor Quality of life · bacterial boils (furuncles and carbuncles) Interventions for bacterial folliculitis and boils (furuncles and carbuncles) (2021) · Cochrane | no estimate extracted | NR | No studies |
Cefditoren pivoxil vs cefaclor Recurrence of folliculitis or boil following completion of treatment · bacterial boils (furuncles and carbuncles) Interventions for bacterial folliculitis and boils (furuncles and carbuncles) (2021) · Cochrane | no estimate extracted | NR | No studies |
Topical antibiotics vs topical antiseptics Recurrence of folliculitis or boil following completion of treatment · bacterial folliculitis and boils (furuncles and carbuncles) Interventions for bacterial folliculitis and boils (furuncles and carbuncles) (2021) · Cochrane | no estimate extracted | NR | No studies |
Topical antibiotics vs topical antiseptics Minor adverse events not leading to withdrawal of treatment · bacterial folliculitis and boils (furuncles and carbuncles) Interventions for bacterial folliculitis and boils (furuncles and carbuncles) (2021) · Cochrane | no estimate extracted | NR | No studies |
Topical antibiotics vs systemic antibiotics Clinical cure · bacterial folliculitis and boils (furuncles and carbuncles) Interventions for bacterial folliculitis and boils (furuncles and carbuncles) (2021) · Cochrane | no estimate extracted | NR | No studies |
Topical antibiotics vs systemic antibiotics Severe adverse events leading to withdrawal of treatment · bacterial folliculitis and boils (furuncles and carbuncles) Interventions for bacterial folliculitis and boils (furuncles and carbuncles) (2021) · Cochrane | no estimate extracted | NR | No studies |
Topical antibiotics vs systemic antibiotics Quality of life · bacterial folliculitis and boils (furuncles and carbuncles) Interventions for bacterial folliculitis and boils (furuncles and carbuncles) (2021) · Cochrane | no estimate extracted | NR | No studies |
Topical antibiotics vs systemic antibiotics Recurrence of folliculitis or boil following completion of treatment · bacterial folliculitis and boils (furuncles and carbuncles) Interventions for bacterial folliculitis and boils (furuncles and carbuncles) (2021) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ NB‐UVB vs PUVA Patient‐reported changes in symptoms ‐ not measured · atopic eczema Phototherapy for atopic eczema (2021) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ NB‐UVB vs PUVA Health‐related quality of life ‐ not measured · atopic eczema Phototherapy for atopic eczema (2021) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ UVA1 vs PUVA Patient‐reported changes in symptoms ‐ not measured · atopic eczema Phototherapy for atopic eczema (2021) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ UVA1 vs PUVA Investigator Global Assessment ‐ not measured · atopic eczema Phototherapy for atopic eczema (2021) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ UVA1 vs PUVA Health‐related quality of life ‐ not measured · atopic eczema Phototherapy for atopic eczema (2021) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ UVA1 vs PUVA Safety: withdrawals due to adverse events ‐ not measured · atopic eczema Phototherapy for atopic eczema (2021) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ NB‐UVB vs placebo Health‐related quality of life ‐ not measured · atopic eczema Phototherapy for atopic eczema (2021) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ NB‐UVB vs UVA1 Investigator Global Assessment ‐ not measured · atopic eczema Phototherapy for atopic eczema (2021) · Cochrane | no estimate extracted | NR | No studies |
Imiquimod vs surgical excision Early treatment failure · adults with basal cell carcinoma of the skin Interventions for basal cell carcinoma of the skin (2020) · Cochrane | no estimate extracted | NR | No studies |
Radiotherapy vs surgical excision (with or without frozen section margin control) Pain · adults with basal cell carcinoma of the skin Interventions for basal cell carcinoma of the skin (2020) · Cochrane | no estimate extracted | NR | No studies |
Radiotherapy vs surgical excision (with or without frozen section margin control) Early treatment failure · adults with basal cell carcinoma of the skin Interventions for basal cell carcinoma of the skin (2020) · Cochrane | no estimate extracted | NR | No studies |
Mohs micrographic surgery vs surgical excision Pain · adults with basal cell carcinoma of the skin Interventions for basal cell carcinoma of the skin (2020) · Cochrane | no estimate extracted | NR | No studies |
Mohs micrographic surgery vs surgical excision Early treatment failure · adults with basal cell carcinoma of the skin Interventions for basal cell carcinoma of the skin (2020) · Cochrane | no estimate extracted | NR | No studies |
Azithromycin (500 mg 20 ‐ 28 days) vs meglumine antimoniate (15 ‐ 20 mg/kg/d Recurrence ‐ not measured · People with American cutaneous and mucocutaneous leishmaniasis Interventions for American cutaneous and mucocutaneous leishmaniasis (2020) · Cochrane | no estimate extracted | NR | No studies |
Topical imiquimod 5% (3 times/week) + meglumine antimoniate (IVMA) (20 mg/kg/d for 20 days) vs placebo + IVMA Recurrence ‐ not measured · People with American cutaneous leishmaniasis Interventions for American cutaneous and mucocutaneous leishmaniasis (2020) · Cochrane | no estimate extracted | NR | No studies |
Thermotherapy one session (at 50 ºC for 30 seconds) vs meglumine antimoniate (20 mg Sb5/kg/day Recurrence ‐ not measured · People with American cutaneous leishmaniasis Interventions for American cutaneous and mucocutaneous leishmaniasis (2020) · Cochrane | no estimate extracted | NR | No studies |
Pentoxifylline (oral 400 mg thrice daily) plus meglumine antimoniate (IMMA) (20 mg/ kg /day for 20 days) vs IMMA plus placebo Recurrence ‐ not measured · People with American cutaneous leishmaniasis Interventions for American cutaneous and mucocutaneous leishmaniasis (2020) · Cochrane | no estimate extracted | NR | No studies |
Oral miltefosine (1.2 to 3.3 mg/kg/d 28 days) vs meglumine antimoniate (20 mg/kg 20 days) Recurrence ‐ not measured · People with American cutaneous and mucocutaneous leishmaniasis Interventions for American cutaneous and mucocutaneous leishmaniasis (2020) · Cochrane | no estimate extracted | NR | No studies |
IFN‐α + PUVA vs PUVA alone Improvement of quality of life · people with mycosis fungoides Interventions for mycosis fungoides (2020) · Cochrane | no estimate extracted | NR | No studies |
IFN‐α + acitretin vs IFN‐α + PUVA Improvement of quality of life · people with mycosis fungoides Interventions for mycosis fungoides (2020) · Cochrane | no estimate extracted | NR | No studies |
IFN‐α + acitretin vs IFN‐α + PUVA Objective response rate · people with mycosis fungoides Interventions for mycosis fungoides (2020) · Cochrane | no estimate extracted | NR | No studies |
IFN‐α + PUVA vs PUVA alone Common adverse effects · people with mycosis fungoides Interventions for mycosis fungoides (2020) · Cochrane | no estimate extracted | NR | No studies |
IFN‐α + PUVA vs PUVA alone Objective response rate (ORR) · people with mycosis fungoides Interventions for mycosis fungoides (2020) · Cochrane | no estimate extracted | NR | No studies |
Extracorporeal photopheresis vs PUVA Improvement of quality of life · people with mycosis fungoides Interventions for mycosis fungoides (2020) · Cochrane | no estimate extracted | NR | No studies |
Bexarotene + PUVA vs PUVA alone Improvement of quality of life · people with mycosis fungoides Interventions for mycosis fungoides (2020) · Cochrane | no estimate extracted | NR | No studies |
Benzoyl peroxide vs erythromycin Participant's global self‐assessment of improvement (long‐term data) ‐ not measured · acne vulgaris Topical benzoyl peroxide for acne (2020) · Cochrane | no estimate extracted | NR | No studies |
Benzoyl peroxide vs salicylic acid Participant's global self‐assessment of improvement (long‐term data) ‐ not measured · acne vulgaris Topical benzoyl peroxide for acne (2020) · Cochrane | no estimate extracted | NR | No studies |
Azelaic acid vs clindamycin Quality of life · participants with acne Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha‐hydroxy acid) for acne (2020) · Cochrane | no estimate extracted | NR | No studies |
Azelaic acid vs tretinoin Total number of participants who experienced at least one minor adverse event · participants with acne Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha‐hydroxy acid) for acne (2020) · Cochrane | no estimate extracted | NR | No studies |
Azelaic acid vs tretinoin Quality of life · participants with acne Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha‐hydroxy acid) for acne (2020) · Cochrane | no estimate extracted | NR | No studies |
Salicylic acid vs benzoyl peroxide Participants' global self‐assessment of acne improvement · participants with acne Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha‐hydroxy acid) for acne (2020) · Cochrane | no estimate extracted | NR | No studies |
Salicylic acid vs pyruvic acid Total number of participants who experienced at least one minor adverse event · participants with acne Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha‐hydroxy acid) for acne (2020) · Cochrane | no estimate extracted | NR | No studies |
Salicylic acid vs pyruvic acid Quality of life · participants with acne Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha‐hydroxy acid) for acne (2020) · Cochrane | no estimate extracted | NR | No studies |
Nicotinamide vs clindamycin Participants' global self‐assessment of acne improvement · participants with acne Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha‐hydroxy acid) for acne (2020) · Cochrane | no estimate extracted | NR | No studies |
Nicotinamide vs clindamycin Quality of life · participants with acne Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha‐hydroxy acid) for acne (2020) · Cochrane | no estimate extracted | NR | No studies |